Autres langues Lophos Holdings Inc.

Actions

MESC

CA5439371066

Marché Fermé - Canadian Securities Exchange Autres places de cotation 20:38:35 14/05/2024			Varia. 5j.	Varia. 1 janv.
0,055 ^CAD	+10,00 %		0,00 %	+37,50 %

28/03	Lophos Holdings Inc. annonce des changements au sein de son conseil d'administration	CI
14/02	Lophos Holdings Inc. finalise le développement d'un nouveau protocole de recherche pour Lophophora Williamsii (Peyote)	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Lophos Pharmaceuticals Corp. Enters Into Letter of Intent to Acquire the Assets of Magicactus.com	06/05
Lophos Pharmaceuticals Corp. Commences Peyote Research Protocol	02/05
Lophos Pharmaceuticals Corp. Expands Peyote Cultivation with the Successful Planting of 3,000 Seeds	25/04
Lophos Pharmaceuticals’ Licensed Site Celebrates Successful Building Occupancy	17/04
ThreeD Capital Inc. and Lophos Holdings Inc. Announce Strategic Partnership	15/04
ThreeD Capital Inc. Announces Securities Purchase Agreement with Lophos Holdings Inc.	15/04
ThreeD Capital Inc. announced that it expects to receive CAD 0.1275 million in funding from Lophos Holdings Inc.	15/04
ThreeD Capital Inc. entered into a securities purchase agreement to acquire 2.5% stake in Lophos Holdings Inc. for CAD 0.05 million.	15/04
Lophos Holdings Inc. Celebrates Successful Conclusion of Inaugural Annual General Meeting, Confirms Board Members and Stock Options Plan	28/03
Lophos Holdings Inc. Announces Board Changes	28/03
Lophos Pharmaceuticals Partners With Carmichael Engineering Ltd. for HVAC Project, Anticipates Expedited Building Occupancy	05/03
Lophos Confirms Appearance at Benzinga Capital Conference in Hollywood, Florida and Finalizes Annual General Meeting	28/02
Lophos Holdings Inc. Finalizes the Development of a New Research Protocol for Lophophora Williamsii	14/02
Lophos Pharmaceuticals Corp. Finalizes the Development of a New Research Protocol for Lophophora Williamsii (Peyote)	14/02
Lophos Pharmaceuticals Corp. Finalizes the Development of a New Synthetic Mescaline Protocol	08/02
Lophos Pharmaceuticals Corp. Finalizes the Development of A New Synthetic Mescaline Protocol	08/02
Lophos Pharmaceuticals Corp. Finalizes Product Release Specifications for Fresh and Dried Peyote (Lophophora williamsii)	31/01
Health Canada Endorses Lophophora Williamsii, Elevating Lophos Holdings Inc. as a Leader in Natural Health Innovation	23/01
Lophos Pharmaceuticals Corp. Receives Health Canada Approval for Expanded Controlled Substance Operations Following HVAC Revisions	22/11
Lophos Holdings Inc.'s Subsidiary Lophos Pharmaceuticals Corp. Receives Health Canada Approval for Expanded Controlled Substance Operations Following HVAC Revisions	22/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Lophos Holdings Inc.

Actions

MESC

CA5439371066

Autres langues

Filtres